StockData
Krystal Biotech, Inc. logo

Krystal Biotech, Inc. (KRYS) stock

KRYSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 11/3052% above fair value
$298.55+0.65 (+0.22%)

Close on Nov 17, 2026Market cap $8.84BP/E 37.4Yield –

Krystal Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Krystal Biotech's enterprise value was $8.29B on Nov 11, 2026, against $5.59B a year earlier. Over the last 5 years it ranged from $929.03M to $10.12B, with a median of $3.83B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.29B+29.3%
2025Dec 31, 2025$6.41B+63.8%
2024Dec 31, 2024$3.92B+33.4%
2023Dec 29, 2023$2.94B+78.8%
2022Dec 30, 2022$1.64B+35.5%
2021Dec 31, 2021$1.21B+35.3%
2020Dec 31, 2020$896.01M+18.6%
2019Dec 31, 2019$755.30M+329.5%
2018Dec 31, 2018$175.84M+219.0%
2017Dec 29, 2017$55.13M–

More Krystal Biotech figures

See a number that looks wrong?